0 results for 'BristolMyers Squibb'
After Cipro Battle, Patent-Busting Is Still Live Issue
Last fall, politicians and the media alike discussed the possibility of "busting" Bayer's patents on Cipro so that the government and generic drug companies could satisfy an alleged shortage of the anthrax-fighting drug. Although Bayer and the U.S. government eventually reached a settlement, the topic of patent-busting could arise again, so the potential problems of such an action merit discussion.Trending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
- 3Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5A RICO Surge Is Underway: Here's How the Allstate Push Might Play Out
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
Resources
Strong & Hanni Solves Storage Woes--Learn How You Can, Too
Brought to you by Filevine
Download Now
Meeting the Requirements of California's SB 553: Workplace Violence Prevention
Brought to you by NAVEX Global
Download Now
The Benefits of Outsourcing Beneficial Ownership Information Filing
Brought to you by Wolters Kluwer
Download Now
The Top 10 AI Use Cases in Private Equity
Brought to you by Ontra
Download Now